KCNJ11 and cancer: Other examples include NaVα-dependent, NaVβ1-mediated process outgrowth and the extent of glibenaclamide-induced inhibition of SUR2-mediated cancer cell proliferation correlating with the mRNA expression of Kir6.2 [213,249].